Mostrando 2,201 - 2,220 Resultados de 6,219 Para Buscar '"leishmaniasis"', tiempo de consulta: 0.89s Limitar resultados
  1. 2201
  2. 2202
  3. 2203
    “…The aims of the study were to assess the prevalence of filarial infection in asymptomatic Leishmania donovani infected individuals and the correlation of Wuchereria bancrofti infection with progression to clinical visceral leishmaniasis (VL) in Bihar, India. METHODOLOGY/PRINCIPAL FINDINGS: Within the Muzaffarpur-TMRC Health and Demographic Surveillance System (HDSS) area, a cohort of Leishmania seropositive (n = 476) or seronegative individuals (n = 1130) were sampled annually for three years for filarial infection and followed for progression to clinical VL. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 2204
    “…Molecular surveillance of resistance is an increasingly important part of vector borne disease control programmes that utilise insecticides. The visceral leishmaniasis (VL) elimination programme in India uses indoor residual spraying (IRS) with the pyrethroid, alpha-cypermethrin to control Phlebotomus argentipes the vector of Leishmania donovani, the causative agent of VL. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 2205
  6. 2206
  7. 2207
  8. 2208
    por Reithinger, Richard, Coleman, Paul G
    Publicado 2007
    “…BACKGROUND: Although Kabul city, Afghanistan, is currently the worldwide largest focus of cutaneous leishmaniasis (CL) with an estimated 67,500 cases, donor interest in CL has been comparatively poor because the disease is non-fatal. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  9. 2209
  10. 2210
    “…BACKGROUND: There are few reports describing the epidemiology of visceral leishmaniasis (VL) in Somalia. Over the years 2002 to 2005, a yearly average of 140 patients were reported from the Huddur centre in Bakool region, whereas in 2006, this number rose to 1002 patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  11. 2211
  12. 2212
  13. 2213
    “…BACKGROUND: High cost, poor compliance, and systemic toxicity have limited the use of pentavalent antimony compounds (SbV), the treatment of choice for cutaneous leishmaniasis (CL). Paromomycin (PR) has been developed as an alternative to SbV, but existing data are conflicting. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  14. 2214
  15. 2215
  16. 2216
    “…In North America (México, United States, and Canada), leishmaniasis is a vector-borne disease that is autochthonous in México and Texas and has begun to expand its range northward. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  17. 2217
  18. 2218
    “…BACKGROUND: Little information is available about infantile visceral leishmaniasis (VL) in Albania as regards incidence, diagnosis and management of the disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  19. 2219
    “…BACKGROUND: Post kala-azar dermal leishmaniasis (PKDL) is a cutaneous form of disease that develops at variable times after individuals have received treatment for clinical visceral leishmaniasis (VL). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  20. 2220
Herramientas de búsqueda: RSS